TPTGF Stock UPDATES Topotarget A/S Copen (TPTGF) 0.6806 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Topotarget A/S Copen (TPTGF) 0.6806 $TPTGF

Therapeutic Report for Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
M2 - Tue Aug 06, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5sqnpw/acute_lymphocytic) has announced the addition of the "Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2012" report to their offering. This report provides an overview of the acute lymphocytic leukemia therapeutic pipeline. It provides information on the therapeutic development for acute lymphocytic leukemia complete with latest updates, and special features on late-stage and discontinued projects. The document is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Scope - A snapshot of the global therapeutic scenario for acute lymphocytic leukemia. - A review of the acute lymphocytic leukemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the acute lymphocytic leukemia pipeline on the basis of route of administration and molecule type. - Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for acute lymphocytic leukemia. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players with the most promising pipeline. - Devise corrective measures for pipeline projects by understanding acute lymphocytic leukemia pipeline depth and focus of acute lymphocytic leukemia therapeutics. Key Topics Covered: List of Tables List of Figures Introduction Report Coverage Acute Lymphocytic Leukemia Overview Therapeutics Development An Overview of Pipeline Products for Acute Lymphocytic Leukemia Companies Involved in Acute Lymphocytic Leukemia Therapeutics Development Drug Profiles Featured News & Press Releases Appendix Companies Mentioned (40) Including: - 4SC AG - Ariad Pharmaceuticals - Bio-Path Holdings - Bristol-Myers Squibb Company - CanBas Co - Exelixis - F. Hoffmann-La Roche - Genzyme Corporation - Hana Biosciences - Incyte Corporation - Jazz Pharmaceuticals - KaloBios Pharmaceuticals - Lentigen Corporation - Millennium Pharmaceuticals - MorphoSys AG - Mundipharma International - Novartis AG - Onconova Therapeutics - Oryzon - Pfizer - Proacta - Sigma-Tau Pharmaceuticals - SuperGen - SymbioTec GmbH - Threshold Pharmaceuticals - TopoTarget A/S - Tragara Pharmaceuticals For more information visit http://www.researchandmarkets.com/research/5s...ymphocytic

T-Cell Lymphomas - Pipeline Review, H2 2012
M2 - Fri Aug 02, 6:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pz4gz2/tcell_lymphomas) has announced the addition of the "T-Cell Lymphomas - Pipeline Review, H2 2012" report to their offering. This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for T-Cell lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for T-Cell lymphomas. The document is built using data and information proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Scope - A snapshot of the global therapeutic scenario for T-Cell lymphomas. - A review of the T-Cell lymphomas products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the T-Cell lymphomas pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for T-Cell lymphomas. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding T-Cell lymphomas pipeline depth and focus of Indication therapeutics. Key Topics Covered: List of Tables List of Figures Introduction Report Coverage T-Cell Lymphomas Overview Therapeutics Development An Overview of Pipeline Products for T-Cell Lymphomas Companies Involved in T-Cell Lymphomas Therapeutics Development T-Cell Lymphomas - Therapeutics Assessment Drug Profiles Featured News & Press Releases Appendix Companies Mentioned: - Abbott Laboratories - Allos Therapeutics, Inc - Amgen Inc - Celgene Corporation - Cephalon - Chipscreen Biosciences Ltd - Eisai Co - Emergent BioSolutions Inc - Incyte Corporation - Kyowa Hakko Kirin Co - Millennium Pharmaceuticals - Mundipharma International Limited - Nerviano Medical Sciences - PharmaMar - Pharmacyclics, Inc - Sareum Holdings - Seattle Genetics, Inc - TopoTarget A/S - Xencor, Inc - ZIOPHARM Oncology For more information visit http://www.researchandmarkets.com/research/pz..._lymphomas

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013
M2 - Fri Apr 12, 5:22AM CDT
Research and Markets has announced the addition of the "Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013" report to their offering. 'Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Peripheral T-Cell Lymphomas (PTCL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peripheral T-Cell Lymphomas (PTCL). Scope - A snapshot of the global therapeutic scenario for Peripheral T-Cell Lymphomas (PTCL). - A review of the Peripheral T-Cell Lymphomas (PTCL) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects o

Soft Tissue Sarcoma - Pipeline Review, H2 2012
M2 - Mon Jan 07, 8:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/f4g9mh/soft_tissue) has announced the addition of Global Markets Direct's new report "Soft Tissue Sarcoma - Pipeline Review, H2 2012" to their offering. 'Soft Tissue Sarcoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Soft Tissue Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Soft Tissue Sarcoma. Soft Tissue Sarcoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Reasons to buy - Identify and understand important and di




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 165

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Arbor Realty Trust Hit with Securities Fraud Lawsuit

Updated Category News Views 98

Snafu at Arbor Realty: Investors Rethink Strategies You know what puts a bee in my bonnet these days? Misleading statements from companies like Arbor Realty Trust, Inc. (NYSE: ABR). The news breaks that Arbor's got itself neck-deep in a class action lawsuit, courtesy of the sharp folks over at Schall, Brown & Schwartz LLP. Now, this ain't your average financial hiccup....

Continue Reading
Radnostix Sees Mixed Results, Plans Strategic Shift

Updated Category News Views 90

Radnostix: A Rocky Third Quarter with Glimmers of Hope Alright, sit back and digest this: Radnostix, the company once known as International Isotopes Inc., is currently in the midst of a renovation of sorts. They just reported their financial results for the third quarter of 2026, and honestly, they're a mixed bag. Revenue Falls but Theranostics Shines Quarterly revenue...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 133

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
League's AI Launch: A New Era in Healthcare

Updated Category News Views 76

AI: Healthcare's Bold New Move Ah, here we go. Another tech jump in healthcare. This time it's the folks over at League, stirring the pot with some new AI gimmicks. They've slapped together what they call an 'AI Front Door' and an 'AI Care Companion'—part of their Forge by League platform. Now, if there's one thing we know, it's that the healthcare sector loves a good...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 126

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Chicken Production Rises Amid Meat Market Shifts

Updated Category News Views 165

Protein Markets Scramble: Chicken Production Climbs Here’s a tasty tidbit that might just have investors reeling: the USDA says chicken production will be cruising on the up, whereas beef is taking a bit of a backseat. Yep, the big birds are flying higher, and the cows, well, they're just mooing a little softer. And what's that mean for big players like Tyson...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 69

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
SKE Capitalizes on Halloween Events in London

Updated Category News Views 120

SKE's Bold Step into London's Halloween Vibe Hah! Who would've thought that vaping and Halloween could be a match made in heaven? This year, SKE threw its hat into the ring and wrestled for attention in London’s bustling Halloween music scene. Imagine an entire warehouse pulsing not just with beat-heavy electronic music, but the energy of vaping enthusiasts courtesy of...

Continue Reading

Top 5 Most Recently Viewed Articles

Trua: Veteran-Led Service Offers Senior Living Help

Updated Category News Views 31

A New Chapter for Senior Living Guidance Life's complexities can be as tough as a two-dollar steak, and let's face it, senior living decisions often top that chart. Greater Boston gets a new lifeline with Trua of Greater Boston breaking into the scene. Not just any placement service, mind you. Run by Jersouk Touy and Jessie Marasco, it promises a blend of personalized,...

Continue Reading
Standex International Corporation Reports Q4 Fiscal 2025 Results

Updated Category News Views 162

Standex International Corporation to Announce Q4 2025 Results Standex International Corporation (NYSE: SXI) is set to unveil its financial results for the fourth quarter of fiscal year 2025 on Thursday. The report will be released after the market closes, providing investors and stakeholders with key insights into the company's performance. Key Details of the Announcement...

Continue Reading
Ireland's €3 Billion Bond Sale Highlights Strong Investor Demand

Updated Category News Views 136

Overview of Ireland's Successful Bond Issuance Dublin has recently seen an impressive move in the financial markets with the National Treasury Management Agency successfully issuing €3 billion in 30-year fixed-rate notes. This significant bond issuance demonstrates the strong appetite from investors without the need for stabilization measures, reflecting confidence in...

Continue Reading
Exciting Developments in Yukon Metals' Birch Copper-Gold Project

Updated Category News Views 196

Significant Updates from the Birch Copper-Gold Project Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) has recently announced thrilling developments concerning its 100%-owned Birch Copper-Gold Project, spanning 7,000 hectares. This project is located approximately 65 kilometres from Burwash Landing and 200 kilometres from Whitehorse. The current drill program aims...

Continue Reading
Krystal Biotech's Upcoming Presentation at Major Healthcare Event

Updated Category News Views 122

Krystal Biotech Set to Attend Major Healthcare Conference Krystal Biotech, Inc. (NASDAQ: KRYS), a company dedicated to leading the way in genetic medicine, has shared an exciting opportunity for both investors and the public. The Company will highlight its latest advancements at the upcoming 2024 Cantor Global Healthcare Conference in New York. This event stands out as...

Continue Reading